Posted in | News | Uranium

Cameco Updates Recent Developments at Cigar Lake Uranium Mine in Northern Saskatchewan

Cameco today provided an update on recent developments at the Cigar Lake uranium mine in northern Saskatchewan.

The Cigar Lake uranium deposit occurs at depths ranging from 410 to 450 metres below the surface where the water-saturated Athabasca sandstone meets the underlying basement rocks. To prevent water from entering the production areas of the mine and to help stabilize weak rock formations, the ore zone and surrounding ground is being frozen by circulating a brine solution through cased holes drilled from both surface and underground.

As part of the ongoing commissioning process, Cameco has been assessing the current state of ground freezing at Cigar Lake. We have determined that freezing has not advanced as quickly as expected in some localized areas of the mine. Given that the McClean Lake mill has not yet started processing Cigar Lake ore, we have decided to temporarily stop jet-boring at Cigar Lake to allow the ore body to freeze more thoroughly in these areas. The additional freezing will allow more continuous production at the mine once the mill is operational.

Based on early indications from our assessment we expect the production schedule could shift by a couple of months. Although a minor change to the schedule, it means ore that was expected to be milled at the end of the year, will shift into early 2015 thereby affecting our 2014 production target. Cameco will provide an update to its 2014 production target in its second quarter MD&A on July 31 when the assessment is complete.

The company's long-term annual production target of 18 million pounds U3O8 by 2018 will not be impacted.

The Cigar Lake mine is owned by Cameco (50.025%), AREVA Resources Canada Inc. (AREVA) (37.1%), Idemitsu Canada Resources Ltd. (7.875%) and TEPCO Resources Inc. (5.0%) and is operated by Cameco. Ore from Cigar Lake will be processed at the McClean Lake mill, which is majority owned and operated by AREVA.

Qualified Person

The above scientific and technical information related to the Cigar Lake mining operation was approved by Scott Bishop, manager, technical services for Cameco, who is a qualified person for the purpose of National Instrument 43-101.

Profile

Cameco is one of the world's largest uranium producers, a significant supplier of conversion services and one of two CANDU fuel manufacturers in Canada. Our competitive position is based on our controlling ownership of the world's largest high-grade reserves and low-cost operations. Our uranium products are used to generate clean electricity in nuclear power plants around the world. We also explore for uranium in the Americas, Australia and Asia. Our shares trade on the Toronto and New York stock exchanges. Our head office is in Saskatoon, Saskatchewan.

Source: http://www.cameco.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Cameco Corporation. (2019, February 17). Cameco Updates Recent Developments at Cigar Lake Uranium Mine in Northern Saskatchewan. AZoMining. Retrieved on April 20, 2024 from https://www.azomining.com/News.aspx?newsID=10171.

  • MLA

    Cameco Corporation. "Cameco Updates Recent Developments at Cigar Lake Uranium Mine in Northern Saskatchewan". AZoMining. 20 April 2024. <https://www.azomining.com/News.aspx?newsID=10171>.

  • Chicago

    Cameco Corporation. "Cameco Updates Recent Developments at Cigar Lake Uranium Mine in Northern Saskatchewan". AZoMining. https://www.azomining.com/News.aspx?newsID=10171. (accessed April 20, 2024).

  • Harvard

    Cameco Corporation. 2019. Cameco Updates Recent Developments at Cigar Lake Uranium Mine in Northern Saskatchewan. AZoMining, viewed 20 April 2024, https://www.azomining.com/News.aspx?newsID=10171.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.